Open AccessResource Use and Costs Associated to the Initial Phase of Treatment for Patients with Colorectal Cancer Receiving Post-Surgery Chemotherapy: A Cost Analysis from a Healthcare Perspective
Author(s) -
Miejati,
Moaven Razavi,
Iraj Harirchi,
Marzieh Zanganeh,
Gholamreza Salari,
Seyed Mosa Tabatabaee
Publication year - 2021
Publication title -
iranian journal of public health
Language(s) - English
Resource type - Journals
eISSN - 2251-6093
pISSN - 2251-6085
DOI - 10.18502/ijph.v50i9.7062
Subject(s) - medicine , colorectal cancer , medical record , health care , chemotherapy , indirect costs , cancer , retrospective cohort study , emergency medicine , intensive care medicine , general surgery , surgery , business , accounting , economics , economic growth
Background: To estimate the resource use and costs associated to the initial phase of treatment for colorectal cancer in Iran.
Methods: A retrospective study was conducted using routinely collected data within Electronic Health Records System (SEPAS), a national database representing public hospitals in Iran between March 20, 2016 and March 19, 2017. Primary end points included healthcare resource use, direct medical and non-medical costs of care in the 12-month study period.
Results: The study population included 657 patients with colorectal cancer who underwent surgery and the follow-up chemotherapy. We estimated a total direct cost of $21,407 per patient. The results indicated that direct medical costs were primarily driven by inpatient hospital care, followed by surgery, chemotherapy, and diagnostic services.
Conclusion: The initial 12-month of treatment for colorectal cancer, including surgery and the follow-up chemotherapy, is resource intensive. The total direct costs associated to the disease are remarkable, with Inpatient hospital services being the main contributor followed by surgery and chemotherapy.